Area of research
Endocrinology, Diabetes and Metabolism · Molecular Biology
Research interest
Research interests include Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Cardiovascular Function and Risk Factors, and Per- and polyfluoroalkyl substances research.
Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway
Corrigendum to “A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice” [Biochem. Biophys. Res. Commun. 621 (2022) 122–129]
Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus
Effect of Semaglutide and Empagliflozin on Pulmonary Structure and Proteomics in Obese Mice
Epidemiological Characterisation of Chronic Diseases Among Civil Servants in Hebei Province, China: A Cross-Sectional Real-World Study of Approximately 50,000 Adults
Effect of High‑Fat-Diet and Semaglutide on Bladder Cancer in Mice
Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression
Association of Neutrophil to High-Density Lipoprotein Cholesterol Ratio with Cardiac Ultrasound Parameters and Cardiovascular Risk: A Cross-Sectional Study Based on Healthy Populations
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
Semaglutide alleviates inflammation-Induced endothelial progenitor cells injury by inhibiting MiR-155 expression in macrophage exosomes
Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study
Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis
Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice
Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
Effect of high-fat diet and empagliflozin on cardiac proteins in mice
Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice
A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice
Correlation between Cardiac Ultrasound Index and Cardiovascular Risk in Healthy Obese and Overweight Populations
Correlation of Obesity and Overweight with Cervical Vascular Function Among Healthy Populations